Korea Investment CORP Acquires 108,300 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Korea Investment CORP raised its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 58.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 294,622 shares of the company’s stock after purchasing an additional 108,300 shares during the quarter. Korea Investment CORP owned 0.06% of GE HealthCare Technologies worth $23,034,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. FMR LLC boosted its holdings in shares of GE HealthCare Technologies by 4.1% in the third quarter. FMR LLC now owns 2,165,826 shares of the company’s stock valued at $203,263,000 after purchasing an additional 84,411 shares during the period. Townsquare Capital LLC lifted its holdings in shares of GE HealthCare Technologies by 21.5% in the 3rd quarter. Townsquare Capital LLC now owns 7,722 shares of the company’s stock worth $725,000 after buying an additional 1,366 shares during the period. Glenmede Trust Co. NA grew its position in shares of GE HealthCare Technologies by 0.6% during the 3rd quarter. Glenmede Trust Co. NA now owns 30,173 shares of the company’s stock worth $2,832,000 after buying an additional 180 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund purchased a new position in shares of GE HealthCare Technologies during the third quarter valued at $2,799,000. Finally, CreativeOne Wealth LLC bought a new stake in shares of GE HealthCare Technologies in the third quarter valued at about $259,000. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $80.01 on Friday. The stock has a 50-day moving average of $86.70 and a two-hundred day moving average of $85.87. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The stock has a market cap of $36.59 billion, a P/E ratio of 18.48, a P/E/G ratio of 3.19 and a beta of 1.13. GE HealthCare Technologies Inc. has a one year low of $74.51 and a one year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. As a group, research analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 25th will be given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.17%. The ex-dividend date is Friday, April 25th. GE HealthCare Technologies’s dividend payout ratio is currently 3.23%.

Analysts Set New Price Targets

A number of research firms have commented on GEHC. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their target price for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. Wells Fargo & Company boosted their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research note on Friday, February 14th. Citigroup increased their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, February 13th. Finally, The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $85.00 to $100.00 in a research report on Tuesday, March 11th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $98.75.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.